Bali Muralidhar

Equibles does not estimate personal net worth.

About Bali Muralidhar

Bali Muralidhar was last confirmed as Board Member at OnKure Therapeutics, Inc. (OKUR) in a filing dated April 22, 2022. Exicure, Inc. reported in an 8-K filed December 30, 2022 that Bali Muralidhar resigned as Board of Directors, effective December 30, 2022. Exicure, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Exicure, Inc. includes Andy Yoo (CEO and Board Member), Brian C. Bock (CEO, CFO and Board Member), Jung Sang (Michael) Kim (CEO, CFO and Board Member) and 7 others.

“Effective December 30, 2022 (the "Resignation Date"), James Sulat and Bali Muralidhar, M.D., Ph.D. each resigned from the Board of Directors (the "Board") of Exicure, Inc. (the "Company").”

Exicure, Inc. Form 8-K, filed December 30, 2022 · Read the filing

Affiliation history

Exicure, Inc. (XCUR)
SEC 8-K

Current
2022-02-04–present
OnKure Therapeutics, Inc. (OKUR)
Board Member

Proxy statement

Start not stated–2022-04-22

Last confirmed by a filing; no departure on record
Exicure, Inc. (XCUR)
Board Member

Proxy statement

Start not stated–2022-12-30